FLT3-IN-15

FLT3-IN-15 is a highly potent and orally active FLT3 inhibitor with IC50s of 0.87 nM and 0.32 nM for FLT3 and FLT3/D835Y, respectively. FLT3-IN-15 can be used for researching acute myeloid leukemia[1].

Product Specifications

CAS Number

[2435562-99-3]

UNSPSC

12352005

Target

FLT3

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/flt3-in-15.html

Solubility

10 mM in DMSO

Smiles

O=C1NC2=C(/C1=C3NC4=CC=CC=C4C/3=N\OCCN5CCNCC5)C=C(C=C2)F.Cl

Molecular Formula

C22H23ClFN5O2

Molecular Weight

443.90

References & Citations

[1]Jeong P, Moon Y, Lee JH, et al. Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia. Eur J Med Chem. 2020;195:112205.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS1096925-01 0.02 mg (E-Coli)

Recombinant Staphylococcus aureus 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG)

Ask

View Details

MBS1096925-02 0.1 mg (E-Coli)

Recombinant Staphylococcus aureus 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG)

Ask

View Details

MBS1096925-03 0.02 mg (Yeast)

Recombinant Staphylococcus aureus 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG)

Ask

View Details

MBS1096925-04 0.1 mg (Yeast)

Recombinant Staphylococcus aureus 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG)

Ask

View Details

MBS1096925-05 0.02 mg (Baculovirus)

Recombinant Staphylococcus aureus 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG)

Ask

View Details

MBS1096925-06 0.02 mg (Mammalian-Cell)

Recombinant Staphylococcus aureus 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG)

Ask

View Details